Granulocyte Colony-stimulating Factor may Promote Proliferation of Human Bladder Cancer Cells Mediated by Basic Fibroblast Growth Factor

References

• Coleman MP, Esteve J, Damiecki P. Arslan A, Renard H. Trends in cancer incidence and mortality. Lyon, France: IARC Scientific Publications, 1993: 543–76.
   Google Scholar
• Sternberg CN, Yagoda A, Scher HI, Watson RC, Ahmed T, Weiselberg LR, et al. Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin, and cisplatin) for transitional cell carcinoma of the urothelium. J Urol 1985; 133: 403–7.
   PubMed Web of Science ®Google Scholar
• Aso Y, Akaza H and the Urological rhG-CSF Study Group. Effect of recombinant human granulocyte colony-stimulating factor in patients receiving chemo-therapy for urogenital cancer. J Urol 1992; 147: 1060–4.
   Google Scholar
• Tachibana M, Miyakawa A, Uchida A, Murai M, Eguchi K, Nakamura K, et al. Granulocyte colony-stimulating factor receptor expression on human transitional cell carcinoma of the bladder. Br J Cancer 1997; 75: 1489–96.
   PubMed Web of Science ®Google Scholar
• Thacker JD, Dedhar S, Hogge DE. The effect of GM-CSF and G-CSF on the growth of human osteosarcoma cells in vitro and in vivo. Int J Cancer 1994; 56: 236–43.
   Google Scholar
• Berdel WE, Danhauser-Riedl S, Oberberg D, Zafferani M. Effect of hematopoietic growth factors on malignant nonhematopoietic cells. Semin Oncol 1992; 19: 41–5.
   PubMed Web of Science ®Google Scholar
• Morel M, Beaujean F, Forestier CL, Hartmann 0, Lemerle J, Duedari N. Effect of human granulocyte colony stimulating factor on neuroblastoma cell growth. Biomed Pharmacother 1993; 47: 29–32.
   Google Scholar
• Avalos BR, Gasson JC, Hedvat C, Quan SG, Baldwin GC, Weisbart RH, et al. Human granulocyte colony-stimulating factor: biologic activities and receptor characterization on hematopoietic cells and small cell lung cancer cell line. Blood 1990; 75: 851–7.
   PubMed Web of Science ®Google Scholar
• Hirai K, Kumakiri M, Fujieda S, Sunaga H, Lao LM, Imamura Y, et al. Expression of granulocyte colony-stimulation factor and its receptor in epithelial skin tumors. J Dermatol Sci 2001; 25: 179–88.
   PubMed Web of Science ®Google Scholar
• Mueller MM, Herold-Mende CC, Riede D, Lange M, Steiner I-1H, Fusenig NE. Autocrine growth regulation by granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor in human gliomas with tumor progression. Am J Pathol 1999; 155: 1557–67.
   Google Scholar
• Block T, Treiber U, Geffken B, Vogel M, Hanauske AR, Schmid F, et al. Inhibitory effects on in vitro cell growth of human urothelial tumor cell lines under the combined administration of hematopoietic growth factors and clinically relevant antineoplastic agents. Urol Res 1993; 21: 217–21.
   PubMedGoogle Scholar
• Akaza H, Fukushima H, Koiso K, Aso Y. Enhancement of chemotherapeutic effects by recombinant human granulocyte colony-stimulating factor on implanted mouse bladder cancer cells (MBT-2). Cancer 1992; 69: 997–1002.
   PubMed Web of Science ®Google Scholar
• Hisazumi H, Kanokogi M, Nakajima K, Kobayashi T, Tsukahara K, Naito K, et al. Established cell line of urinary bladder carcinoma (KK-47): growth, hetero-transplantation, microscopic structure and chromosome pattern. Jpn J Urol 1979; 70: 485–94.
   PubMedGoogle Scholar
• Bubenik J, Baresova M, Viklicky V. Jakoubkova J, Sainerova H, Donner J. Established cell line of urinary bladder carcinoma (T24) containing tumor-specific antigen. Int J Cancer 1973; 11: 765–73.
   Google Scholar
• Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55–63.
   PubMed Web of Science ®Google Scholar
• Myoken Y, Myoken Y, Okamoto T, Kan M, Mckeehan WL, Sato JD, et al. Expression of fibroblast growth factor-1 (FGF-1), FGF-2 and FGF receptor-1 in a human salivary-gland adenocarcinoma cell line: evidence of autocrine growth. Int J Cancer 1996; 65: 650–7.
   PubMed Web of Science ®Google Scholar
• Brandstetter T, Ninci E, Bettendorf H, Perewusnyk G, Stolte J, Herchenbach D, et al. Granulocyte colony-stimulating factor (G-CSF) receptor gene expression of ovarian carcinoma does not correlate with G-CSF caused cell proliferation. Cancer 2001; 91: 1372–83.
   PubMed Web of Science ®Google Scholar
• Tachibana M, Miyakawa A, Tazaki H, Nakamura K, Kubo A, Hata J, et al. Autocrine growth of transitional cell carcinoma of the bladder induced by granulocyte-colony stimulating factor. Cancer Res 1995; 55: 3438–43.
   PubMed Web of Science ®Google Scholar
• Ohigashi T, Tachibana M, Tazaki H, Nakamura K. Bladder cancer cells express functional receptors for granulocyte-colony stimulating factor. J Urol 1992; 147: 283–6.
   PubMed Web of Science ®Google Scholar
• Shameem IA, Kuris H, Matsuyama H, Shimabukuro T, Naito K. Direct and indirect effects of recombinant human granulocyte-colony stimulating factor on in vitro colony formation of human bladder cancer cells. Cancer Immunol Immunother 1994; 38: 353–7.
   Google Scholar
• Hamburger AW, Salmon SE. Primary bioassay of human tumor stem cells. Science 1977; 197: 461–3.
   PubMed Web of Science ®Google Scholar
• Matsuyama H, Yoshihiro S, Ohmoto Y, Yamamoto N, Naito K. Direct and indirect effects of human interferon a on renal cell carcinoma: a new in vitro assay system for evaluating cytokine-mediated antitumor effects. Cancer Immunol Immunother 1993; 37: 84–8.
   Google Scholar
• Avalos BR. Molecular analysis of the granulocyte colony-stimulating factor receptor. Blood 1996; 88: 761–77.
   PubMed Web of Science ®Google Scholar
• Allen LE, Maher PA. Expression of basic fibroblast growth factor and its receptor in an invasive bladder carcinoma cell line. J Cell Physiol 1993; 155: 368–75.
   PubMed Web of Science ®Google Scholar
• Takauji R, Tohyama K, Ueda T, Nakamura T. Enhance-ment of cytosine arabinoside cytotoxicity by granulo-cyte/macrophage colony-stimulating factor and granulo-cyte colony-stimulating factor in a human myeloblastic leukemia cell line. Jpn J Cancer Res 1993; 84: 445–50.
   PubMedGoogle Scholar
• Estey E, Thall P. Andreeff M, Beran M, Kantarjian H, O'Brien S, et al. Use of granulocyte colony-stimulating factor before, during, and after fludarabine plus cy-tarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: comparison with fludarabine plus cytarabine without granulocyte colony-stimulating factor. J Clin Oncol 1994; 12: 671–8.
   Google Scholar
• Ohno R, Naoe T, Kanamaru A, Yoshida M, Hiraoka A, Kobayashi T, et al. A double-blind controlled study of granulocyte colony-stimulating factor started two days before induction chemotherapy in refractory acute myeloid leukemia. Blood 1994; 83: 2086–92.
   PubMed Web of Science ®Google Scholar